The disease is not transmitted from person to person by any other method known to science but genetic.Heredity determines the likelihood of the disease, but does not guarantee its occurrence in future generations.It is likely that vitiligo can be triggered by several factors, including the impact of the external environment.
disease is autoimmune in nature - the body alone destroys the melanocytes (cells that produce the skin pigment melanin), seeing them as potentially dangerous for life.Among the causes of this immune response observed a large amount of stress, disorders of the respiratory system, sunburn, skin damage, and severe cuts large, long-term exposure to chemicals.Some doc
estimated that only about 1% of people have symptoms of the disease.The appearance of the disease is not caused by any age, race or gender.The most common phenomenon is diagnosed in patients older than 20 years.The intensity of vitiligo depends on the individual health indicators.It is possible that the extent of the disease is genetically determined.
Symptoms of vitiligo include the appearance of skin discolorations.This marked a gradual increase in the resulting colorless area and its spread throughout the body.In some cases, the disease manifests headache and dizziness.Perhaps the hair loss and the appearance of the characteristic rash.
noted that the disease begins to progress quickly under the influence of ultraviolet radiation, physical and emotional stress.To avoid worsening symptoms, you should refrain from prolonged exposure to sunlight as much as possible and keep a relaxed lifestyle.
Vitiligo is not treatable.To reduce the speed of its development doctor may prescribe phototherapy.Commonly prescribed corticosteroid drugs (creams and pills), the rate of vitamin D and local immune modulators.To hide skin stains, you can use a variety of cosmetics.If untreated, may increase the area of skin depigmented spots and a significant deterioration in the quality of life.Nevertheless, the disease is not fatal, however, people with this disease are at increased risk of developing other autoimmune processes, e.g., pernicious anemia or diabetes first type.